Fegueux N - Search Results

1

Infusion of in vivo expanded cord blood lymphocytes: A new strategy to control residual disease?

Lamure S, Delage J, Vincent L, Fegueux N, Zhao-Yang L, Cartron G, Ceballos P, De Vos J. Lamure S, et al. Among authors: fegueux n. Curr Res Transl Med. 2018 Sep;66(3):91-93. doi: 10.1016/j.retram.2018.02.003. Epub 2018 Mar 7. Curr Res Transl Med. 2018. PMID: 29525419 Free article. No abstract available.

2

Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients.

Quittet P, Ceballos P, Lopez E, Lu ZY, Latry P, Becht C, Legouffe E, Fegueux N, Exbrayat C, Pouessel D, Rouillé V, Daures JP, Klein B, Rossi JF. Quittet P, et al. Among authors: fegueux n. Bone Marrow Transplant. 2006 Aug;38(4):275-84. doi: 10.1038/sj.bmt.1705441. Bone Marrow Transplant. 2006. PMID: 16883311 Free PMC article. Clinical Trial.

3

Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake.

Eiden C, Meniane JC, Peyrière H, Eymard-Duvernay S, Le Falher G, Ceballos P, Fegueux N, Cociglio M, Reynes J, Hillaire-Buys D. Eiden C, et al. Among authors: fegueux n. Eur J Clin Microbiol Infect Dis. 2012 Feb;31(2):161-7. doi: 10.1007/s10096-011-1288-9. Epub 2011 May 26. Eur J Clin Microbiol Infect Dis. 2012. PMID: 21611869

4

Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma.

Vincent L, Ceballos P, Plassot C, Méniane JC, Quittet P, Navarro R, Cyteval C, Szablewski V, Lu ZY, Kanouni T, Moreaux J, Cartron G, Klein B, Fegueux N. Vincent L, et al. Among authors: fegueux n. Blood Cancer J. 2015 Aug 21;5(8):e341. doi: 10.1038/bcj.2015.48. Blood Cancer J. 2015. PMID: 26295611 Free PMC article. No abstract available.

5

A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).

Platon L, Amigues L, Ceballos P, Fegueux N, Daubin D, Besnard N, Larcher R, Landreau L, Agostini C, Machado S, Jonquet O, Klouche K. Platon L, et al. Among authors: fegueux n. Bone Marrow Transplant. 2016 Feb;51(2):256-61. doi: 10.1038/bmt.2015.269. Epub 2015 Nov 16. Bone Marrow Transplant. 2016. PMID: 26569092

6

Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission.

Baron F, Labopin M, Ruggeri A, Volt F, Mohty M, Blaise D, Chevallier P, Sanz J, Fegueux N, Cornelissen JJ, Rambaldi A, Savani BN, Gluckman E, Nagler A. Baron F, et al. Among authors: fegueux n. J Intern Med. 2019 Apr;285(4):446-454. doi: 10.1111/joim.12870. Epub 2019 Jan 18. J Intern Med. 2019. PMID: 30561052 Free article.

7

Third autologous stem cell transplants for late relapse of multiple myeloma.

Jourdan E, Blaise D, Fegueux N, Navarro R, Rossi JF, Maraninchi D, Navarro M. Jourdan E, et al. Among authors: fegueux n. Bone Marrow Transplant. 1996 May;17(5):885-6. Bone Marrow Transplant. 1996. PMID: 8733716

8

Immunotherapy by non-myeloablative allogeneic stem cell transplantation in multiple myeloma: results of a pilot study as salvage therapy after autologous transplantation.

Garban F, Attal M, Rossi JF, Payen C, Fegueux N, Sotto JJ; Intergroupe Francophone du Myelome. Garban F, et al. Among authors: fegueux n. Leukemia. 2001 Apr;15(4):642-6. doi: 10.1038/sj.leu.2402081. Leukemia. 2001. PMID: 11368368

9

Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy.

Mohty M, Fegueux N, Exbrayat C, Lu ZY, Legouffe E, Quittet P, Lopez-Martinez E, Latry P, Avinens O, Hertog C, Klein B, Eliaou JF, Rossi JF. Mohty M, et al. Among authors: fegueux n. Bone Marrow Transplant. 2001 Aug;28(4):335-9. doi: 10.1038/sj.bmt.1703134. Bone Marrow Transplant. 2001. PMID: 11571504

10

Autologous peripheral blood stem cell transplantation following heart transplantation for primary systemic amyloidosis.

Mohty M, Albat B, Fegueux N, Rossi JF. Mohty M, et al. Among authors: fegueux n. Leuk Lymphoma. 2001 Mar;41(1-2):221-3. doi: 10.3109/10428190109057976. Leuk Lymphoma. 2001. PMID: 11342379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page